CoreCap Advisors’s 10x Genomics TXG Stock Holding History

CoreCap Advisors’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$158K	Buy	1,752 +1,700	+3,269%	+$99.5K	﹤0.01%	935
2026 Q2	$1.99K	Hold	52	–	–	﹤0.01%	2533
2026 Q1	$1.1K	Hold	52	–	–	﹤0.01%	2522
2025 Q4	$848	Buy	52 +50	+2,500%	+$755	﹤0.01%	2626
2025 Q3	$23	Hold	2	–	–	﹤0.01%	2769
2025 Q2	$23	Sell	2 -39	-95%	-$355	﹤0.01%	2731
2025 Q1	$358	Buy	41 +39	+1,950%	+$492	﹤0.01%	2776
2024 Q4	$29	Hold	2	–	–	﹤0.01%	2813
2024 Q3	$45	Hold	2	–	–	﹤0.01%	2580
2024 Q2	$39	Hold	2	–	–	﹤0.01%	1560
2024 Q1	$75	Buy	+2	New	+$88	﹤0.01%	2460
2022 Q4	$146	Buy	+4	New	+$131	﹤0.01%	2288
2022 Q3	–	Sell	-4	Closed	–	–	1983
2022 Q2	$0	Buy	+4	New	+$208	﹤0.01%	2277
2022 Q1	–	Sell	-5	Closed	-$1K	–	1987
2021 Q4	$1K	Buy	+5	New	+$766	﹤0.01%	2262

Other funds holding TXG

Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

CoreCap Advisors's TXG Position: Q3 2026 in Review

CoreCap Advisors increased its 10x Genomics (TXG) stake by 3,269% in Q3 2026, buying an estimated $99.5K and bringing the position to 1,752 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #935.

CoreCap Advisors first reported a position in TXG in Q4 2021 and has held it in 14 quarters since. 69 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

CoreCap Advisors held 1,752 shares of 10x Genomics worth $158K as of Q3 2026.
CoreCap Advisors bought 1,700 10x Genomics shares in Q3 2026, an estimated $99.5K.
10x Genomics made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #935 holding.
CoreCap Advisors first reported a position in 10x Genomics in Q4 2021 and has held it in 14 quarters since.
69 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.